Skip to main content

Table 2 Results of pre- and post-intervention scores within groups

From: An old approach to a novel problem: effect of combined balance therapy on virtual reality induced motion sickness: a randomized, placebo controlled, double-blinded study

 

Intervention (n = 60)

 

Placebo control (n = 61)

 

Pre-test

Post-test

p

Pre-test

Post-test

p

VRSQ Total

80.65 ± 10.01

46.23 ± 16.79

< 0,001

78.54 ± 12.43

74.24 ± 13.69

0.067

VRSQ Oculomotor

35.46 ± 4.83

21.15 ± 7.98

< 0,001

34.57 ± 5.93

33.82 ± 6.17

0.494

VRSQ Discomfort

45.18 ± 5.70

25.08 ± 8.93

< 0,001

43.19 ± 6.71

41.15 ± 38.17

0.125

Tolerance (minute)

8.13 ± 2.93

12.75 ± 2.64

< 0,001

7.88 ± 2.58

8.73 ± 2.85

0.116

VAS (mm)

28.58 ± 16.30

56.98 ± 22.09

< 0,001

45.86 ± 19.77

54.29 ± 20.87

0.031

OSI

0.45 ± 0.21

0.35 ± 0.28

0.043

0.50 ± 0.27

0.49 ± 0.26

0.561

FBT

10.19 ± 1.50

9.51 ± 1.99

0,021

10.12 ± 2.57

9.85 ± 1.92

0.158

  1. VRSQ Virtual reality sickness questionnaire: VAS Visual analogue scale: OSI Overall stability index: FBT Flamingo balance test: Paired sample t-test, p < 0.05